Disability

Enlivex Receives Notice of Allowance for Chinese Patent Application Covering the Use of Allocetra in Patients with OsteoarthritisEnlivex Receives Notice of Allowance for Chinese Patent Application Covering the Use of Allocetra in Patients with Osteoarthritis

Enlivex Receives Notice of Allowance for Chinese Patent Application Covering the Use of Allocetra in Patients with Osteoarthritis

Nes-Ziona, Israel, March 17, 2025 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the “Company”), a clinical-stage macrophage reprogramming immunotherapy…

2 weeks ago
Waterdrop Inc. Announces Fourth Quarter and Fiscal Year 2024 Unaudited Financial Results and a Cash DividendWaterdrop Inc. Announces Fourth Quarter and Fiscal Year 2024 Unaudited Financial Results and a Cash Dividend

Waterdrop Inc. Announces Fourth Quarter and Fiscal Year 2024 Unaudited Financial Results and a Cash Dividend

BEIJING, March 12, 2025 /PRNewswire/ -- Waterdrop Inc. ("Waterdrop", the "Company" or "we") (NYSE: WDH), a leading technology platform dedicated…

3 weeks ago
Lindus Health and Sooma Medical announce pivotal device clinical trial for treatment of MDDLindus Health and Sooma Medical announce pivotal device clinical trial for treatment of MDD

Lindus Health and Sooma Medical announce pivotal device clinical trial for treatment of MDD

BOSTON, March 11, 2025 /PRNewswire/ -- Lindus Health, the "anti-CRO" running radically faster, more reliable clinical trials for life science…

3 weeks ago
Progyny Expands Family Building Solutions with New Parent and Child Well-being OfferingProgyny Expands Family Building Solutions with New Parent and Child Well-being Offering

Progyny Expands Family Building Solutions with New Parent and Child Well-being Offering

The in-demand program provides high-touch, holistic support for working parents and caregivers, addressing return-to-work challenges, emotional health support, and benefit…

3 weeks ago
Kaerus Bioscience Successfully Completes Phase 1 Trial and Demonstrates Proof of Mechanism with its Novel BK Channel Modulator KER-0193 being developed for Fragile X SyndromeKaerus Bioscience Successfully Completes Phase 1 Trial and Demonstrates Proof of Mechanism with its Novel BK Channel Modulator KER-0193 being developed for Fragile X Syndrome

Kaerus Bioscience Successfully Completes Phase 1 Trial and Demonstrates Proof of Mechanism with its Novel BK Channel Modulator KER-0193 being developed for Fragile X Syndrome

LONDON, March 11, 2025 (GLOBE NEWSWIRE) -- Kaerus Bioscience (www.kaerusbio.com), a clinical-stage biopharmaceutical company created by Medicxi for the development…

3 weeks ago
BARUCH COLLEGE: NOTICE OF SECURITY INCIDENTBARUCH COLLEGE: NOTICE OF SECURITY INCIDENT

BARUCH COLLEGE: NOTICE OF SECURITY INCIDENT

NEW YORK, March 6, 2025 /PRNewswire/ -- Baruch College ("Baruch"), a public college in New York City, is providing notice of…

4 weeks ago
CENTER FOR THE HELPING PROFESSIONS LAUNCHESCENTER FOR THE HELPING PROFESSIONS LAUNCHES

CENTER FOR THE HELPING PROFESSIONS LAUNCHES

Nashville, TN-based NonProfit Focused on Improving Systems Through Safety Science and Evidence-Based Approaches NASHVILLE, Tenn., March 6, 2025 /PRNewswire/ -- The…

4 weeks ago
HyBryte™ Treatment Studies Presented at Two Medical Conferences in MarchHyBryte™ Treatment Studies Presented at Two Medical Conferences in March

HyBryte™ Treatment Studies Presented at Two Medical Conferences in March

Two Presentations Highlight Data Demonstrating Hypericin Photodynamic Therapy Potential with a Preliminary Comparison to Current Therapy PRINCETON, N.J., March 6,…

4 weeks ago
Sun Life is named a strategic Workday Wellness partner to make benefits easier for employers through enhanced data connectivitySun Life is named a strategic Workday Wellness partner to make benefits easier for employers through enhanced data connectivity

Sun Life is named a strategic Workday Wellness partner to make benefits easier for employers through enhanced data connectivity

WELLESLEY, Mass., March 5, 2025 /PRNewswire/ -- Sun Life U.S., a leading provider of employee benefits and human resource technology solutions,…

4 weeks ago
KENCREST BOARD NAMES AURORA KRIPA ITS NEXT CEOKENCREST BOARD NAMES AURORA KRIPA ITS NEXT CEO

KENCREST BOARD NAMES AURORA KRIPA ITS NEXT CEO

She will replace President and CEO Marian Baldini who will be retiring in December BLUE BELL, Pa., March 3, 2025…

1 month ago